价格

GG-3

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CXCL8 BINDING NUCLEIC ACIDS
EP 3880822 A1申请人: APTARION BIOTECH AG优先权: 2018
CN
EP
US
WO
6 件公开
Modulation of Fas and FasL expression
- US 7662792 B2
  申请人: BIONICHE LIFE SCIENCES INC优先权: 2001
  US
  3 件公开
- WO 0218593 A3
  申请人: BIONICHE LIFE SCIENCES INC优先权: 2000
  WO
COSMETIC PRODUCT HAVING A METAL CAN, AND THE CONTENTS OF SAME
WO 2016134963 A1申请人: BEIERSDORF AG优先权: 2015
CN
WO
2 件公开
POLYPEPTIDE HAVING MODIFIED STRUCTURE AND USE THEREOF
EP 4624486 A4申请人: GUANGDONG RAYNOVENT BIOTECH CO LTD优先权: 2023
CN
EP
2 件公开
GNRH PEPTIDE ANTIGEN, PHARMACEUTICAL COMPOSITION CONTAINING GNRH PEPTIDE ANTIGEN, AND USE THEREOF
WO 2026171099 A1申请人: SUZHOU AFFECTION ANIMAL PHARMACEUTICALS CO LTD优先权: 2025
CN
WO
2 件公开
Probiotic gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in human
US 9644210 B2申请人: SCHREZENMEIR JÜRGEN优先权: 2013
US
2 件公开
Fungicidal compositions and methods of making thereof
US 6291513 B1申请人: MONSANTO CO优先权: 2000
US
Methods for regulating transcription by targeting quadruplex DNA
US 7405041 B2申请人: UNIV ARIZONA优先权: 2003
US
Peptides Having For Example Antiangiogenic Activity and Applications Thereof In Therapeutics
US 2008171697 A1申请人: JACOTOT ETIENNE优先权: 2003
US
Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method
US 2006009429 A1申请人: KERNER NESTOR A优先权: 2003
US

药物

GG-3

专利

Modulation of Fas and FasL expression